Followers | 0 |
Posts | 885 |
Boards Moderated | 0 |
Alias Born | 02/15/2016 |
Monday, January 29, 2018 9:46:13 AM
"On this last slide, we provide a summary of our upcoming drug development milestones over the next several quarters. We expect to complete preclinical studies in the first half of 2018. We anticipate filing an IND investigational new drug application sometime in Q3 2018 and we anticipate commencing human trials in late 2018. We expect to provide updates as they are available over the next several quarters on our drug development program."
These things take time. My guess is not before 2021. Whether it sells via over the counter near the other nrts or via doctor/pharmacy im not sure. what we have on our side is fda is downright obsessed with nicotine and tobacco addition right now.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM